Pravin Kaumaya | Professor and Director Vaccine Research
The Ohio State University Werner Medical Center

Pravin Kaumaya, Professor and Director Vaccine Research, The Ohio State University Werner Medical Center

Kaumaya is Professor of Medicine in Department of Ob/Gyn at the OSU Wexner Medical Center and the James Comprehensive Cancer Center. Dr Kaumaya is internationally recognized as an expert in the fields of vaccine research with emphasis on peptide vaccines for cancer, viral diseases as well as peptide therapy for autoimmune diseases. He conducts research in the areas of tumor immunology, mechanisms of tumor cell-immune cell interactions, and immune mechanisms. The laboratory functions as an integrated translational research program with the goal of designing and developing new immunotherapies and immunologic strategies for cancer treatment and prevention. He is an inventor on several issued and pending patents for Peptide Vaccines and Therapeutic Technologies. He has lectured worldwide and has published over 130 peer-reviewed articles in major scientific journals Dr. Kaumaya is an elected fellow of the American Association for the Advancement of Science (AAAS), and he was elected as the treasurer of the American Peptide Society since 2009. Dr Kaumaya has conducted a first man/woman NCI funded and FDA approved Phase 1 Trial in Cancer Patients (Stage 4) with solid tumors in several indications (Breast, Ovarian, GIST) at the OSU James Cancer Hospital has recently been completed successfully.


WVIC/WAC Day 1 - Nov 29 @ 16:20

Novel Checkpoint Inhibitor Combination Vaccines (PD-1, PD-L1, CTLA-4, TIGIT, LAG3)

WVIC/WAC Day 3 - Dec 1 @ 12:30

Showcase 3: Engineering a novel SARS-CoV2 B-cell epitope vaccine and investigation in transgenic K18-hACE2 mice

last published: 01/Dec/22 17:25 GMT

back to speakers

For conference programme and speaking opportunities:
Lauren Sheppard

For sponsorship and exhibition opportunities:
Thomas Hall